Quantum Cyber NV

Quantum Cyber NV (QUCY) Stock Analysis

$1.570

+0.166 (+10.56%)At close

Loading chart…
High
1.580
Open
1.420
VWAP
1.51
Vol
1.36M
Mkt Cap
Low
1.380
Amount
2.06M
EV/EBITDA, TTM
-0.72

Quantum Cyber N.V., formerly known as Mainz Biomed N.V., is a Germany‑based technology company engaged in the development of solutions in the fields of quantum computing and cybersecurity. The Company focuses on safeguarding digital infrastructure against emerging quantum‑related risks through technologies such as post‑quantum cryptography and defence‑related systems. Its activities include the development of applications supporting secure data protection and communication, as well as the establishment of a platform for quantum‑focused security technologies.

AI analysis of Quantum Cyber NV (QUCY)

buy

Mainz Biomed NV (QUCY) appears to be a good buy right now due to its recent strong performance, with a year-to-date change of +68.23% and a positive market reaction to significant orders worth $2.09 million. However, the main risk is the potential dilution from the CEO's $6 million investment, which could impact existing shareholders if he sells his shares.

Valuation Metrics

The current forward P/E ratio for Quantum Cyber NV (QUCY) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-0.65
Current EV/EBITDA
-0.72
Overvalued
-0.39
Undervalued
-0.92

Forward P/S

Fair
5Y Average P/S
20.41
Current P/S
26.09
Overvalued
28.52
Undervalued
12.31

Events Timeline

2026-08-31 (ET)

09:30:00

Quantum Cyber Completes Installation of 80 Units of 3D Printing Drone Production Line

2026-08-20 (ET)

16:30:00

Quantum Cyber Receives Blackmail Threat, Continues Lawsuit

2026-08-12 (ET)

16:00:00

Quantinuum Partners with Oracle for Quantum Computing

2026-07-27 (ET)

09:30:00

Quantum Cyber Produces First Mini-Interceptor Drone in Connecticut

2026-07-16 (ET)

08:00:00

Quantum Cyber Reports Purchase Orders of Approximately $2.09M

News

QUCY FAQ — answered by Alphio AI

Quantum Cyber N.V., formerly known as Mainz Biomed N.V., is a Germany‑based technology company engaged in the development of solutions in the fields of quantum computing and cybersecurity. The Company focuses on safeguarding digital infrastructure against emerging quantum‑related risks through technologies such as post‑quantum cryptography and defence‑related systems. Its activities include the development of applications supporting secure data protection and communication, as well as the establishment of a platform for quantum‑focused security technologies. It operates in the Technology sector.

Mainz Biomed NV (QUCY) appears to be a good buy right now due to its recent strong performance, with a year-to-date change of +68.23% and a positive market reaction to significant orders worth $2.09 million. However, the main risk is the potential dilution from the CEO's $6 million investment, which could impact existing shareholders if he sells his shares.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started